Report Description Table of Contents In 2020, the Global Multiplex Assays Market share was USD 3.13 billion. It is predicted to reach USD 6.47 billion by 2030, representing a CAGR of 7.53 percent throughout the forecasted period. Multiplex assay is one of the most crucial derivatives of an ELISA using beads to bind the "capture" antibody. The "capture" antibody helps in binding and retaining the analyte from the sample. Market Dynamics: - Market Drivers: - (Rising numbers of NCDs and infectious diseases, and the increase in use of multiplex assays in companion diagnostics) The continuous rising prevalence of chronic (non-communicable) and infectious diseases across the globe is one of the major factors that is augmenting the overall market growth throughout the estimated time frame. According to the World Health Organization, chronic/ non-communicable diseases (NCD) kill 41 Mn people each year, which is equivalent to 71% of all the deaths occurring globally. Each year, more than 15 Mn people between the ages of (30 to 69) years die due to an NCD. Approximately 85% of these "premature" deaths occur in middle and low-income countries. CVDs (cardiovascular diseases) are the most common type of NCD, which leads to the highest number of deaths worldwide (i.e., 17.9 Mn people annually), followed by cancers (9.3 Mn), respiratory diseases (4.1 Mn), and diabetes (1.5 Mn). Also, as per the National Institutes of Health, 5 types of infectious diseases are ranked among the top ten killer diseases worldwide, namely lower respiratory infections diseases (3.4 Mn deaths), HIV/AIDS (2.6 Mn deaths), diarrheal diseases (1.8 Mn deaths), tuberculosis (1.6 Mn deaths), and malaria (1.1 Mn deaths). Apart from the increase of chronic and infectious diseases, the rising awareness of disease diagnosis, the rising prevalence of multiplex assays in companion diagnostics, the requirement for effective analytical platforms in R&D is propelling the overall market growth significantly. Further, the rise in usage of several advanced technologies and processes like multiplex bead array assays, xmap assay, invitrogen luminex, cytokine immunoassay, milliplex merck, rnascope v2, magpix assay, msd cytokine multiplex, magpix cytokine assay, rnascope multiplex fluorescent v2 assay, milliplex multiplex assays, xmap luminex, multiplex assays ELISA, etc. are fuelling the growth of the market worldwide. Restraints: - (Expensive equipments & stringent regulations) The higher costs of the equipment are one of the major factors restraining the overall market growth, as it constantly challenges the manufacturers and researchers to perform the multiplex assay testing at an affordable cost. Also, the standards for Quality control (Q.C.) of the multiplex assays are more stringent than the single-plex assays, thereby obstructing the overall market growth. Opportunities:(The increase in the need of automated systems and the rising prevalence of the biomarkers in protein and molecular diagnostics at the Asia-Pacific region) Multiple biomarker analysis has a major application in the area of autoimmune diseases, cancer, and neurodegenerative diseases. With the discovery of a large number of biomarkers, there is a higher probability for the development of new diagnostic tests in the Asia-Pacific region, which is expected to create ample growth opportunities in the future. Also, the latest development in the Technology of an automated multiplex assay instrument is expected to boost the overall market growth, which will help the market grow exponentially in the future. Global Multiplex Assays Market: - Analysis of different Segmentations: The Global Multiplex Assays Market segmentation is performed based on Product & Service, Type, Technology, Applications, End-User, and Regions. Based on Product and Service Instruments Consumables Software and Services Based on Type Nucleic Acid Multiplex Assays Planar Nucleic Acid Assays Bead-Based Nucleic Acid Assays Others Protein Multiplex Assays Planar Protein Assays Bead-Based Protein Assays Others Cell-Based Multiplex Assays Based on Technology Fluorescence Detection Luminescence Flow Cytometry Multiplex Real-Time PCR Others Based on Applications Research & Development Biomarker Discovery & Validation Drug Discovery & Development Clinical Diagnostics Cancer Cardiovascular Diseases Infectious Diseases Autoimmune Diseases Metabolism & Endocrinology Disorders Nervous System Disorders Others Based on End-User Hospitals & Research Institutes Pharmaceutical & Biotechnology Companies Reference Laboratories Others Based on Regions: North America U.S. Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on Product & Service, the 'Consumables' segment held the highest share of almost 44.27% of the entire market in 2020. It also held the fastest rate of growth with a decent CAGR throughout the forecasted period. The vital factors like the higher usage of reagents for facilitating research applications on consumables and the increase in the number of recurring purchases of assays worldwide are fuelling this segment's overall growth. Based on Type, the 'Protein Multiplex Assays' segment dominated the overall market with a steady CAGR during the estimated period owing to the sheer focus on proteomics studies for clinical diagnostics and biomarker research. According to IBISWorld, in 2021, there will be about 28,393 Diagnostic & Medical Laboratory businesses in the United States, with an increase of nearly 1.5 percent from 2020. Based on Technology, the 'Flow Cytometry' segment held the largest share (approximately 37.28%) of the entire market in 2020 with a decent CAGR of 8.27%. The largest share of this segment can primarily be attributed to the wide range of flow cytometry applications in the measurement and detection of RNA, protein expression, and cell viability & toxicity, along with the identification and characterization of various cell types. Based on Applications, the 'Research & Development' segment dominated the market in 2020 due to the increase of funds by the worldwide governments on the broad applications of multiplex assay technologies in R&D functions. The R&D outsourcing services market is accelerating at a CAGR of 7.93%, which in turn is propelling the overall growth of this segment. Based on End User, the 'Pharmaceutical & Biotechnology Companies' segment accounted for the highest market share in 2020. Factors such as the rising focus of biotechnological companies on developing monoclonal and biosimilars antibodies and the increase in the number of adoptions of multiplex assays in the field of drug discovery by pharmaceuticals are significantly driving the overall growth of this segment. Based on Regions, North America held the largest regional market share with a CAGR of 8.93% in 2020, followed by Europe. The highest share of the North American region can primarily be attributed to the presence of leading pharmaceutical and biotechnology companies, established pharmaceutical industries, and increased R&D expenditures by the government. In the United States, Multiplex Assays Market is significantly higher than any other country worldwide. In addition, the government spending for the clinical services laboratory has increased by approximately 5.23% between 2010 to 2020, which has highly boosted the Multiplex Assays Market in the United States. Global Multiplex Assays Market: Competitive Landscape Analysis The competitive landscape analysis provides informationabout the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites, and facilities, market potential, etc. The key players that are included in the Global Multiplex Assays Market report are: Luminex Corporation Illumina Inc Bio-Rad Laboratories, Inc. Qiagen N.V. Thermo Fisher Scientific Inc Abcam plc Merck KGaA Agilent Technologies, Inc. Becton, Dickinson, and Company Meso Scale Diagnostics Randox Laboratories Quanterix Bio-Techne Corporation Olink DiaSorin S.p.A. Seegene Promega Corporation Siemens Healthineers PerkinElmer Inc. Shimadzu Biotech Antigenix America, Inc. Enzo Life Sciences, Inc. Boster Biological Technology AYOXXA Biosystems GmbH Cayman Chemical Company Global Multiplex Assays Market: Recent Developments On August 25th, 2021, Becton, Dickinson, and Company launched its new automated high-throughput diagnostic BD COR System. The system uses sample management software algorithms and robotics technology to set up a new standard in molecular testing automation for infectious diseases in core laboratories in the United States. On April 20th, 2021, Illumina successfully acquired GRAIL, a world-renowned healthcare company focused on providing early life-saving detection of multiple types of cancers. However, during the European Commission's ongoing regulatory review, Illumina will hold GRAIL as a separate company. On February 26th, 2021, Thermo Fisher Scientific succeeded in acquiring Mesa Biotech, a privately held POC (point-of-care) molecular diagnostic company. By the combination of Thermo Fisher's excellence in operations, existing sales and distribution channels with Mesa's innovative platform, direct access to the raw materials, rapid scaling of manufacturing volume can be performed with ease. The list of key products that are developed by global market leaders PRODUCT NAME FUNCTION COMPANY Invitrogen Instant ELISA kits The instant ELISA Kits has ready-to-use plates that contain all the necessary assay components like lyophilized detection antibody, capture antibody, sample diluent, and streptavidin-HRP. These plates help in the reduction of pipetting time and also enable a simple one-wash type of protocol. Thermo Fisher Scientific Inc Human IL-6 ELISA Kit II It is designed in such a brilliant way that it can successfully measure the total amount of targeted bound between a matched pair of antibodies. Becton, Dickinson, and Company SIMOA Acts as an accelerator or catalyst in the Laboratoryfor Protein biomarker testing processes. Quanterix ADVIA Centaur XPT Immunoassay System It is one of the highest-throughput systems that can ever be available. It delivers the perfect results on which the clinicians depend upon for better patient care and accurate diagnoses. Siemens Healthineers Frequently Asked Question About This Report How big is the Global Multiplex Assays Market? In 2020, the Global Multiplex Assays Market share was USD 3.13 billion. It is predicted to reach USD 6.47 billion by 2030, representing a CAGR of 7.53 percent throughout the forecasted period. Which is the most dominant type of product and service in the Global Multiplex Assays Market? Based on Product and Service, the Consumables segment held the highest share of almost 44.27% of the entire market in 2020. Which is the most leading segment among the End-User of the Global Multiplex Assays Market? Based on End User, the Pharmaceutical & Biotechnology Companies segment accounted for the highest market share in 2020. Who are the essential players of the Global Multiplex Assays Market? The most vital players of the Global Multiplex Assays Market are Luminex Corporation, Illumina Inc, Bio-Rad Laboratories, Inc, Qiagen N.V., Thermo Fisher Scientific Inc, Abcam plc, Merck KGaA, Agilent Technologies, Inc, Becton, Dickinson and Company, Meso Scale Diagnostics, Randox Laboratories, Quanterix, Bio-Techne Corporation, Olink, DiaSorin S.p.A., Seegene, Promega Corporation, Siemens Healthineers, PerkinElmer Inc, Shimadzu Biotech, Antigenix America, Inc, Enzo Life Sciences, Inc, Boster Biological Technology, AYOXXA Biosystems GmbH, and Cayman Chemical Company. na 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Multiplex Assays Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Multiplex Assays Market 4.2.1 Global Multiplex Assays market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Multiplex Assays market, by Region, 2020 - 2028 (USD Million) 4.4 By Product and Service Analysis 4.4.1 Global Multiplex Assays market, By Product and Service, 2020 - 2028 (USD Million) 4.5 By Technology Business Analysis 4.5.1 Global Multiplex Assays market, By Technology, 2020 - 2028 (USD Million) 4.6 By Type Analysis 4.6.1 Global Multiplex Assays market, By Type, 2020 - 2028 (USD Million) 4.7 By End-User Business Analysis 4.7.1 Global Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 4.8 Application Business Analysis 4.8.1 Global Multiplex Assays market, By Application, 2020 - 2028 (USD Million) 4.9 Value Chain Analysis 4.10 Market Variable Analysis 4.10.1 Market Drivers Analysis 4.10.2 Market Restraints Analysis 4.11 Business Environment Analysis Tool 4.11.1 Multiplex Assays market PEST analysis 4.11.2 Multiplex Assays market Porter’s analysis 4.12 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Multiplex Assays Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Multiplex Assays Manufacturing Sites, Area Served, Product Type 6.3. Multiplex Assays Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Multiplex Assays Market: By Product and Service Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2020-2028) 7.3. Instruments 7.3.1. Instruments market, 2020 - 2028 (USD Million) 7.4. Consumables 7.4.1. Consumables market, 2020 - 2028 (USD Million) 7.5 Software and Services 7.5.1 Software and Services market, 2020 - 2028 (USD Million) 8. Global Multiplex Assays Market: By Technology Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2020-2028) 8.3. Fluorescence Detection 8.3.1. Fluorescence Detection market, 2020 - 2028 (USD Million) 8.4. Luminescence 8.4.1. Luminescence market, 2020 - 2028 (USD Million) 8.5 Flow Cytometry 8.5.1 Flow Cytometry market, 2020 - 2028 (USD Million) 8.6 Multiplex Real-Time PCR 8.6.1 Multiplex Real-Time PCR market, 2020 - 2028 (USD Million) 8.7 Others 8.7.1 Others market, 2020 - 2028 (USD Million) 9. Global Multiplex Assays Market: By Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2020-2028) 9.3. Nucleic Acid Multiplex Assays 9.3.1. Nucleic Acid Multiplex Assays market, 2020 - 2028 (USD Million) 9.3.1.1 Planar Nucleic Acid Assays market, 2020 - 2028 (USD Million) 9.3.1.2 Bead-Based Nucleic Acid Assays market, 2020 - 2028 (USD Million) 9.3.1.3 Others market, 2020 - 2028 (USD Million) 9.4. Protein Multiplex Assays 9.4.1. Protein Multiplex Assays market, 2020 - 2028 (USD Million) 9.4.1.1 Planar Protein Assays market, 2020 - 2028 (USD Million) 9.4.1.2 Bead-Based Protein Assays market, 2020 - 2028 (USD Million) 9.4.1.3 Others market, 2020 - 2028 (USD Million) 9.5 Cell-Based Multiplex Assays 9.5.1 Cell-Based Multiplex Assays market, 2020 - 2028 (USD Million) 10. Global Multiplex Assays Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2020-2028) 10.3. Hospitals & Research Institutes 10.3.1. Hospitals & Research Institutes market, 2020 - 2028 (USD Million) 10.4. Pharmaceutical & Biotechnology Companies 10.4.1. Pharmaceutical & Biotechnology Companies market, 2020 - 2028 (USD Million) 10.5 Reference Laboratories 10.5.1 Reference Laboratories market, 2020 - 2028 (USD Million) 10.6 Others 10.6.1 Others market, 2020 - 2028 (USD Million) 11. Global Multiplex Assays Market: By Application Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2020-2028) 11.3. Research & Development 11.3.1. Research & Development market, 2020 - 2028 (USD Million) 11.3.1.1 Biomarker Discovery & Validation market, 2020 - 2028 (USD Million) 11.3.1.1 Drug Discovery & Development market, 2020 - 2028 (USD Million) 11.4. Clinical Diagnostics 11.4.1. Clinical Diagnostics market, 2020 - 2028 (USD Million) 11.4.1.1 Cancer market, 2020 - 2028 (USD Million) 11.4.1.2 Cardiovascular Diseases market, 2020 - 2028 (USD Million) 11.4.1.3 Infectious Diseases market, 2020 - 2028 (USD Million) 11.4.1.4 Autoimmune Diseases market, 2020 - 2028 (USD Million) 11.4.1.5 Metabolism & Endocrinology Disorders market, 2020 - 2028 (USD Million) 11.4.1.6 Nervous System Disorders market, 2020 - 2028 (USD Million) 11.4.1.7 Others market, 2020 - 2028 (USD Million) 12. Global Multiplex Assays Market: Regional Outlook 12.1 North America 12.1.1. North America Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.1.4. North America Multiplex Assays market, By Application, 2020 - 2028 (USD Million) 12.1.5. North America Multiplex Assays market, by Country, 2020 - 2028 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.1.4.2.2. Canada Multiplex Assays market, By Region, 2020 - 2028 (USD Million) 12.1.4.2.3. Canada Multiplex Assays market, by Applications, 2020 - 2028 (USD Million) 12.2. Europe 12.2.1. Europe Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.2.2. Europe Multiplex Assays market, by By Application, 2020 - 2028 (USD Million) 12.2.5. Europe Multiplex Assays market, by country, 2020 - 2028 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.2.4.1.2. U.K. Multiplex Assays market, By Applications, 2020 - 2028 (USD Million) 12.2.4.1.3. U.K. Multiplex Assays market, by Region, 2020 - 2028 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.2.4.2.2. Germany Multiplex Assays market, By Application, 2020 - 2028 (USD Million) 12.2.4.2.3. Germany Multiplex Assays market, by Region, 2020 - 2028 (USD Million) 12.2.4.3. France 12.2.4.3.1. France Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.2.4.3.2. France Multiplex Assays market, By Region, 2020 - 2028 (USD Million) 12.2.4.3.3. France Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.2.4.4.2. Rest of Europe Multiplex Assays market, By Region, 2020 - 2028 (USD Million) 12.2.4.4.3. Rest of Europe Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.2. Asia Pacific Multiplex Assays market, By Application, 2020 - 2028 (USD Million) 12.3.5. Asia Pacific Multiplex Assays market, by country, 2020 - 2028 (USD Million) 12.3.4.1. China 12.3.4.1.1. China Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.4.1.2. China Multiplex Assays market, By Region, 2020 - 2028 (USD Million) 12.3.4.1.3. China Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.3.4.2. India 12.3.4.2.1. India Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.4.2.2. India Multiplex Assays market, By Region, 2020 - 2028 (USD Million) 12.3.4.2.3. India Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. Japan Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.4.3.3. Japan Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.4.4.3. South Korea Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFIC Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFIC Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.4. Latin America 12.4.1. Latin America Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.4.3. Latin America Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.4.4. Latin America Multiplex Assays market, by country, 2020 - 2028 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.4.4.1.3. Brazil Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.4.4.2.3. Mexico Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin America Multiplex Assays market, By End-User, 2020 - 2028 (USD Million) 12.4.4.3.3. Rest of the Latin America Multiplex Assays market, by Application, 2020 - 2028 (USD Million) 13. Competitive Landscape 13.1 Luminex Corporation 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. Illumina Inc 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. Bio-Rad Laboratories, Inc. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. Qiagen N.V. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. Thermo Fisher Scientific Inc 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Abcam plc 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. Merck KGaA 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Agilent Technologies, Inc. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development 13.9. Becton, Dickinson, and Company 13.9.1. Company overview 13.9.2. Financial performance 13.9.3. Product Portfolio Analysis 13.9.4. Business Strategy & Recent Development 13.10. Meso Scale Diagnostics 13.10.1. Company overview 13.10.2. Financial performance 13.10.3. Product Portfolio Analysis 13.10.4. Business Strategy & Recent Development 13.11. Randox Laboratories 13.11.1. Company overview 13.11.2. Financial performance 13.11.3. Product Portfolio Analysis 13.11.4. Business Strategy & Recent Development 13.12. Quanterix 13.12.1. Company overview 13.12.2. Financial performance 13.12.3. Product Portfolio Analysis 13.12.4. Business Strategy & Recent Development 13.13. Bio-Techne Corporation 13.13.1. Company overview 13.13.2. Financial performance 13.13.3. Product Portfolio Analysis 13.13.4. Business Strategy & Recent Development 13.14. Olink 13.14.1. Company overview 13.14.2. Financial performance 13.14.3. Product Portfolio Analysis 13.14.4. Business Strategy & Recent Development 13.15. DiaSorin S.p.A. 13.15.1. Company overview 13.15.2. Financial performance 13.15.3. Product Portfolio Analysis 13.15.4. Business Strategy & Recent Development 13.16. Seegene 13.16.1. Company overview 13.16.2. Financial performance 13.16.3. Product Portfolio Analysis 13.16.4. Business Strategy & Recent Development 13.17. Promega Corporation 13.17.1. Company overview 13.17.2. Financial performance 13.17.3. Product Portfolio Analysis 13.17.4. Business Strategy & Recent Development 13.18. Siemens Healthineers 13.18.1. Company overview 13.18.2. Financial performance 13.18.3. Product Portfolio Analysis 13.18.4. Business Strategy & Recent Development 13.19. PerkinElmer Inc. 13.19.1. Company overview 13.19.2. Financial performance 13.19.3. Product Portfolio Analysis 13.19.4. Business Strategy & Recent Development 13.20. Shimadzu Biotech 13.20.1. Company overview 13.20.2. Financial performance 13.20.3. Product Portfolio Analysis 13.20.4. Business Strategy & Recent Development 13.21. Antigenix America, Inc. 13.21.1. Company overview 13.21.2. Financial performance 13.21.3. Product Portfolio Analysis 13.21.4. Business Strategy & Recent Development 13.22. Enzo Life Sciences, Inc. 13.22.1. Company overview 13.22.2. Financial performance 13.22.3. Product Portfolio Analysis 13.22.4. Business Strategy & Recent Development 13.23. Boster Biological Technology 13.23.1. Company overview 13.23.2. Financial performance 13.23.3. Product Portfolio Analysis 13.23.4. Business Strategy & Recent Development 13.24. AYOXXA Biosystems GmbH 13.24.1. Company overview 13.24.2. Financial performance 13.24.3. Product Portfolio Analysis 13.24.4. Business Strategy & Recent Development 13.25. Cayman Chemical Company 13.25.1. Company overview 13.25.2. Financial performance 13.25.3. Product Portfolio Analysis 13.25.4. Business Strategy & Recent Development List of Tables (86 Tables) TABLE 1. Multiplex Assays MARKET, By Product and Service, 2020-2028 (USD Million) TABLE 2. Multiplex Assays MARKET FOR Instruments, BY REGION, 2020-2028 (USD Million) TABLE 3. Multiplex Assays MARKET FOR Consumables, BY REGION, 2020-2028 (USD Million) TABLE 4. Multiplex Assays MARKET FOR Software and Services, BY REGION, 2020-2028 (USD Million) TABLE 5. Multiplex Assays MARKET, By Technology, 2020-2028 (USD Million) TABLE 6. Multiplex Assays MARKET FOR Fluorescence Detection, BY REGION, 2020-2028 (USD Million) TABLE 7. Multiplex Assays MARKET FOR Luminescence, BY REGION, 2020-2028 (USD Million) TABLE 8. Multiplex Assays MARKET FOR Flow Cytometry, BY REGION, 2020-2028 (USD Million) TABLE 9. Multiplex Assays MARKET FOR Multiplex Real-Time PCR, BY REGION, 2020-2028 (USD Million) TABLE 10. Multiplex Assays MARKET FOR Others, BY REGION, 2020-2028 (USD Million) TABLE 11. Multiplex Assays MARKET, By Type, 2020-2028 (USD Million) TABLE 12. Multiplex Assays MARKET FOR Nucleic Acid Multiplex Assays, BY REGION, 2020-2028 (USD Million) TABLE 13. Multiplex Assays MARKET FOR Protein Multiplex Assays, BY REGION, 2020-2028 (USD Million) TABLE 14. Multiplex Assays MARKET FOR Cell-Based Multiplex Assays, BY REGION, 2020-2028 (USD Million) TABLE 15. Multiplex Assays MARKET, By End-User, 2020-2028 (USD Million) TABLE 16. Multiplex Assays MARKET FOR Hospitals & Research Institutes, BY REGION, 2020-2028 (USD Million) TABLE 17. Multiplex Assays MARKET FOR Pharmaceutical & Biotechnology Companies, BY REGION, 2020-2028 (USD Million) TABLE 18. Multiplex Assays MARKET FOR Reference Laboratories, BY REGION, 2020-2028 (USD Million) TABLE 19. Multiplex Assays MARKET FOR Others, BY REGION, 2020-2028 (USD Million) TABLE 20. Multiplex Assays MARKET, BY APPLICATION, 2020-2028 (USD Million) TABLE 21. Multiplex Assays MARKET FOR Research & Development, BY REGION, 2020-2028 (USD Million) TABLE 22. Multiplex Assays MARKET FOR Clinical Diagnostics, BY REGION, 2020-2028 (USD Million) TABLE 23. Multiplex Assays MARKET, BY REGION, 2020-2028 (USD Million) TABLE 24. NORTH AMERICA Multiplex Assays MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 25. NORTH AMERICA Multiplex Assays MARKET, BY Applications, 2020-2028 (USD Million) TABLE 26. NORTH AMERICA Multiplex Assays MARKET, By End-User, 2020-2028 (USD Million) TABLE 27. NORTH AMERICA Multiplex Assays MARKET, BY APPLICATION, 2020-2028 (USD Million) TABLE 28. EUROPE Multiplex Assays MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 29. EUROPE Multiplex Assays MARKET, By End-User, 2020-2028 (USD Million) TABLE 30. EUROPE Multiplex Assays MARKET, BY APPLICATION, 2020-2028 (USD Million) TABLE 31. ASIA-PACIFIC Multiplex Assays MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 32. ASIA-PACIFIC Multiplex Assays MARKET, By End-User, 2020-2028 (USD Million) TABLE 33. ASIA-PACIFIC Multiplex Assays MARKET, BY APPLICATION, 2020-2028 (USD Million) TABLE 34. LAMEA Multiplex Assays MARKET, BY COUNTRY, 2020-2028 (USD Million) TABLE 35. LAMEA Multiplex Assays MARKET, By End-User, 2020-2028 (USD Million) TABLE 36. LAMEA Multiplex Assays MARKET, BY APPLICATION, 2020-2028 (USD Million) TABLE 37. Luminex Corporation: COMPANY SNAPSHOT TABLE 38. Luminex Corporation: OPERATING SEGMENTS TABLE 39. Illumina Inc: COMPANY SNAPSHOT TABLE 40. Illumina Inc: OPERATING SEGMENTS TABLE 41. Bio-Rad Laboratories, Inc: COMPANY SNAPSHOT TABLE 42. Bio-Rad Laboratories, Inc: OPERATING SEGMENTS TABLE 43. Qiagen N.V.: COMPANY SNAPSHOT TABLE 44. Qiagen N.V.: OPERATING SEGMENTS TABLE 45. Thermo Fisher Scientific Inc: COMPANY SNAPSHOT TABLE 46. Thermo Fisher Scientific Inc: OPERATING SEGMENTS TABLE 47. Abcam plc: COMPANY SNAPSHOT TABLE 48. Abcam plc: OPERATING SEGMENTS TABLE 49. Merck KGaA: COMPANY SNAPSHOT TABLE 50. Merck KGaA: OPERATING SEGMENTS TABLE 51. Agilent Technologies, Inc: COMPANY SNAPSHOT TABLE 52. Agilent Technologies, Inc: OPERATING SEGMENTS TABLE 53. Becton, Dickinson, and Company: COMPANY SNAPSHOT TABLE 54. Becton, Dickinson, and Company: OPERATING SEGMENTS TABLE 55. Meso Scale Diagnostics: COMPANY SNAPSHOT TABLE 56. Meso Scale Diagnostics: OPERATING SEGMENTS TABLE 57. Randox Laboratories: COMPANY SNAPSHOT TABLE 58. Randox Laboratories: OPERATING SEGMENTS TABLE 59. Quanterix: COMPANY SNAPSHOT TABLE 60. Quanterix: OPERATING SEGMENTS TABLE 61. Bio-Techne Corporation: COMPANY SNAPSHOT TABLE 62. Bio-Techne Corporation: OPERATING SEGMENTS TABLE 63. Olink: COMPANY SNAPSHOT TABLE 64. Olink: OPERATING SEGMENTS TABLE 65. DiaSorin S.p.A.: COMPANY SNAPSHOT TABLE 66. DiaSorin S.p.A.: OPERATING SEGMENTS TABLE 67. Seegene: COMPANY SNAPSHOT TABLE 68. Seegene: OPERATING SEGMENTS TABLE 69. Promega Corporation: COMPANY SNAPSHOT TABLE 70. Promega Corporation: OPERATING SEGMENTS TABLE 71. Siemens Healthineers: COMPANY SNAPSHOT TABLE 72. Siemens Healthineers: OPERATING SEGMENTS TABLE 73. PerkinElmer Inc: COMPANY SNAPSHOT TABLE 74. PerkinElmer Inc: OPERATING SEGMENTS TABLE 75. Shimadzu Biotech: COMPANY SNAPSHOT TABLE 76. Shimadzu Biotech: OPERATING SEGMENTS TABLE 77. Antigenix America, Inc: COMPANY SNAPSHOT TABLE 78. Antigenix America, Inc: OPERATING SEGMENTS TABLE 79. Enzo Life Sciences, Inc: COMPANY SNAPSHOT TABLE 80. Enzo Life Sciences, Inc: OPERATING SEGMENTS TABLE 81. Boster Biological Technology: COMPANY SNAPSHOT TABLE 82. Boster Biological Technology: OPERATING SEGMENTS TABLE 83. AYOXXA Biosystems GmbH: COMPANY SNAPSHOT TABLE 84. AYOXXA Biosystems GmbH: OPERATING SEGMENTS TABLE 85. Cayman Chemical Company: COMPANY SNAPSHOT TABLE 86. Cayman Chemical Company: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 Multiplex Assays Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Multiplex Assays Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Multiplex Assays Market: Application-Based Estimation Figure 6 Top 25 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Multiplex Assays, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Multiplex Assays, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Multiplex Assays Market, By Product and Service, 2019 vs. 2025 (USD Million) Figure 12 Multiplex Assays Market, By Technology, 2019 vs. 2025 (USD Million) Figure 13 Multiplex Assays Market, By Type, 2019 vs. 2025 (USD Million) Figure 14 Multiplex Assays Market, By End-User, 2019 vs. 2025 (USD Million) Figure 15 Multiplex Assays Market Share, By Application Type, 2019 vs. 2025 Figure 16 Geographical Snapshot of the Multiplex Assays Market Figure 17 Consumables to Witness Higher CAGR in Multiplex Assays Market for Product and Service Segment during Forecast Period. Figure 18 Flow Cytometry to Witness Higher CAGR in Multiplex Assays Market for Technology Segment during Forecast Period. Figure 19 Protein Multiplex Assays to Witness Higher CAGR in Multiplex Assays Market for Type Segment during Forecast Period. Figure 20 Pharmaceutical & Biotechnology Companies to Witness Higher CAGR in Multiplex Assays Market for End-User Segment during Forecast Period. Figure 21 Research & Development to Witness Higher CAGR in Multiplex Assays Market for Application Segment during Forecast Period. Figure 22 North America Accounted for the Largest Share of the Multiplex Assays Market, By Regional Basis, in 2019 Figure 23 Multiplex Assays Market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: Multiplex Assays Market Snapshot Figure 25 Asia Pacific: Multiplex Assays Market Snapshot Figure 26 Vendor Dive: Evaluation Overview